Zobrazeno 1 - 10
of 85
pro vyhledávání: '"David R Minor"'
Autor:
F Stephen Hodi, Ahmad A Tarhini, John M Kirkwood, Zeynep Eroglu, Henry B Koon, Ni Kang, Vernon K Sondak, Harriet M Kluger, Sandra J Lee, Gary I Cohen, Laura F Hutchins, Donald P Lawrence, Kari L Kendra, David R Minor, Carrie B Lee, Mark R Albertini, Lawrence E Flaherty, Teresa M Petrella
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Background The impact of immune-related adverse events (irAEs) occurring from adjuvant use of immunotherapy and of their management on relapse-free survival (RFS) and overall survival (OS) outcomes is currently not well understood.Patients and method
Externí odkaz:
https://doaj.org/article/6f596cfb2e7048f7b2e60a6a21991735
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
BackgroundImmunotherapy has revolutionized the treatment of patients with advanced melanoma as well as other cancers. Most studies, whether of interleukin-2 or checkpoint inhibitor therapies, have limited follow-up after 5 years, making the incidence
Externí odkaz:
https://doaj.org/article/2fd1c212131541e38968831fda7349d0
Autor:
Elham Vosoughi, Jee Min Lee, James R. Miller, Mehdi Nosrati, David R. Minor, Roy Abendroth, John W. Lee, Brian T. Andrews, Lewis Z. Leng, Max Wu, Stanley P. Leong, Mohammed Kashani-Sabet, Kevin B. Kim
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-7 (2018)
Abstract Background Melanoma brain metastasis is associated with an extremely poor prognosis, with a median overall survival of 4–5 months. Since 2011, the overall survival of patients with stage IV melanoma has been significantly improved with the
Externí odkaz:
https://doaj.org/article/486e831d368142f881409d2a8c76d6ac
Publikováno v:
Journal of Global Oncology, Vol 4, Pp 1-3 (2017)
Externí odkaz:
https://doaj.org/article/3f1566059331468d951eaece96e482d5
Autor:
Gary I. Cohen, Carrie B. Lee, David R. Minor, Jeffrey A. Sosman, John M. Kirkwood, Zeynep Eroglu, Sandra J. Lee, Howard Streicher, Donald P. Lawrence, Omid Hamid, Laura F. Hutchins, Lawrence E. Flaherty, Henry B. Koon, Teresa M. Petrella, Mark R. Albertini, H. Kluger, F. Stephen Hodi, Uma N. M. Rao, Vernon K. Sondak, Ahmad A. Tarhini, Kari Kendra
Publikováno v:
Journal of Clinical Oncology. 38:567-575
PURPOSE Phase III adjuvant trials have reported significant benefits in both relapse-free survival (RFS) and overall survival (OS) for high-dose interferon alfa (HDI) and ipilimumab at 10 mg/kg (ipi10). E1609 evaluated the safety and efficacy of ipil
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a9cb1cde27d5249801ed9b18cd818e
https://doi.org/10.1200/jco.19.01381
https://doi.org/10.1200/jco.19.01381
Autor:
David R. Minor, Kevin B. Kim, Ricky T. Tong, Max C. Wu, Mohammed Kashani-Sabet, Marlana Orloff, David J. Eschelman, Carlin F. Gonsalves, Robert D. Adamo, Pramila R. Anne, Jason J. Luke, Devron Char, Takami Sato
Publikováno v:
Cancer biotherapyradiopharmaceuticals. 37(1)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9fe72b9bc0ee01ff16a7d3d3a0d6d5df
https://pubmed.ncbi.nlm.nih.gov/35021863
https://pubmed.ncbi.nlm.nih.gov/35021863
Autor:
David R. Minor, Mark R. Albertini, Gary I. Cohen, Ahmad A. Tarhini, Sandra J. Lee, John M. Kirkwood, Harriet M. Kluger, Howard Streicher, Lawrence E. Flaherty, Henry B. Koon, Carrie B. Lee, Ni Kang, Kari Kendra, Jeffrey A. Sosman, Laura F. Hutchins, Zeynep Eroglu, Teresa M. Petrella, F. Stephen Hodi, Omid Hamid, Donald P. Lawrence, Vernon K. Sondak
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)
BackgroundThe impact of immune-related adverse events (irAEs) occurring from adjuvant use of immunotherapy and of their management on relapse-free survival (RFS) and overall survival (OS) outcomes is currently not well understood.Patients and methods
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2da6985b0925659134397ffbd1cee236
http://europepmc.org/articles/PMC8108687
http://europepmc.org/articles/PMC8108687
Autor:
Ricky T. Tong, Mohammed Kashani-Sabet, Carlin F. Gonsalves, David J. Eschelman, Kevin B. Kim, Max Wu, Devron H. Char, Takami Sato, Marlana Orloff, Jason J. Luke, Robert D. Adamo, David R. Minor, Promila R. Anne
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a4511bf5b6988c18625a4bdb4a3f37dc
https://doi.org/10.2139/ssrn.3885645
https://doi.org/10.2139/ssrn.3885645
Autor:
Howard Striecher, Gary I. Cohen, Teresa M. Petrella, Kari Kendra, H. Kluger, Sandra J. Lee, Lawrence E. Flaherty, Ni Kang, F. Stephen Hodi, Jeffrey A. Sosman, Omid Hamid, Carrie B. Lee, Laura F. Hutchins, Donald P. Lawrence, Henry B. Koon, Vernon K. Sondak, Mark R. Albertini, John M. Kirkwood, David R. Minor, Zeynep Eroglu, Ahmad A. Tarhini
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Background Sex differences in tumor immunity and response to immunotherapy were shown in murine models and descriptive analyses from recent clinical trials. Female sex hormones have been implicated in melanoma development and response to systemic the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::358ab2ec0b89e8eb146d7fa320650442
https://doi.org/10.1136/jitc-2020-sitc2020.0312
https://doi.org/10.1136/jitc-2020-sitc2020.0312
Autor:
Pierre-Yves Desprez, Kevin B. Kim, Elham Vosoughi, David de Semir, Kashish Chetal, David R. Minor, Michelle B. Chen, Brian M. Parrett, Stanley P. L. Leong, Altaf A. Dar, Ryan J Ice, Mark I. Singer, Sean D. McAllister, Nathan Salomonis, Mehdi Nosrati, Liliana Soroceanu, Mohammed Kashani-Sabet, James R. Miller, Jeffrey S. Ross, John Moretto, Anukana Bhattacharjee, Sherri Z. Millis
Publikováno v:
The Journal of investigative dermatology. 141(8)
Homologous recombination DNA damage repair (HR-DDR) deficient patients with various solid tumors have been treated with PARP inhibitors. However, the clinical characteristics of patients with melanoma who have HR-DDR gene mutations and the consequenc
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f1c4cf77dba2c69e883eff273d246f0
https://pubmed.ncbi.nlm.nih.gov/33610559
https://pubmed.ncbi.nlm.nih.gov/33610559